Enhancement of cisplatin antitumar activity by ethyldeshydroxy-sparsomycin

被引：0
|
作者：
Hofs, H.P.
Wagener, D.J.TH.
De Valk-Bakker, V.
Biermans, F.C.M.
Ottenheim, H.C.J.
机构：
来源：
Proceedings of the International Symposium on Metal Ions in Biology and Medicine | 1990年
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] INVIVO POTENTIATION OF CISPLATIN ANTITUMOR-ACTIVITY BY ETHYLDESHYDROXY-SPARSOMYCIN
    HOFS, HP
    WAGENER, DJT
    OTTENHEIJM, HCJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (05) : 1716 - 1717
  • [2] ANTITUMOR-ACTIVITY AND RETINOTOXICITY OF ETHYLDESHYDROXY-SPARSOMYCIN IN MICE
    HOFS, HP
    WAGENER, DJT
    DEVOS, D
    OTTENHEIJM, HCJ
    WINKENS, HJ
    BOVEE, PHM
    DEGRIP, WJ
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A (09) : 1526 - 1530
  • [3] POTENTIATION OF CISPLATIN ANTITUMOR-ACTIVITY BY ETHYLDESHYDROXY-SPARSOMYCIN IN L1210 LEUKEMIA
    HOFS, HP
    WAGENER, DJT
    DEVALKBAKKER, V
    VANRENNES, H
    VANZEIST, AJ
    VANDENBROEK, LAGM
    OTTENHEIJM, HCJ
    [J]. ANTICANCER RESEARCH, 1992, 12 (01) : 167 - 170
  • [4] The effect of ethyldeshydroxy-sparsomycin and cisplatin on the intracellular glutathione level and glutathione S-transferase activity
    Hofs, HP
    Wagener, TDJ
    deValkBakker, V
    vanRennes, H
    Doesburg, WH
    Ottenheijm, HCJ
    deGrip, WJ
    [J]. ANTI-CANCER DRUGS, 1997, 8 (04) : 349 - 357
  • [5] SCHEDULE-DEPENDENT ENHANCEMENT OF ANTITUMOR-ACTIVITY OF ETHYLDESHYDROXY-SPARSOMYCIN IN COMBINATION WITH CLASSICAL ANTINEOPLASTIC AGENTS
    HOFS, HP
    WAGENER, DJT
    DEVALKBAKKER, V
    VANRENNES, H
    DEVOS, D
    DOESBURG, WH
    OTTENHEIJM, HCJ
    DEGRIP, WJ
    [J]. ANTI-CANCER DRUGS, 1995, 6 (02) : 277 - 284
  • [6] CONCENTRATION AND SEQUENCE-DEPENDENT SYNERGISM OF ETHYLDESHYDROXY-SPARSOMYCIN IN COMBINATION WITH ANTITUMOR AGENTS
    HOFS, HP
    WAGENER, DJT
    DEVALKBAKKER, V
    VANRENNES, H
    OTTENHEIJM, HCJ
    DEGRIP, WJ
    [J]. ANTI-CANCER DRUGS, 1994, 5 (01) : 35 - 42
  • [7] ENHANCEMENT OF CISPLATIN MUTAGENICITY IN THE AMES TEST BY SPARSOMYCIN, AN INHIBITOR OF PROTEIN-SYNTHESIS
    ZYLICZ, Z
    BOS, PR
    THEUWS, JLG
    WAGENER, DJT
    SPETH, PAJ
    VANDENBROEK, LAGM
    OTTENHEIJM, HCJ
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 339 - 339
  • [8] INVIVO POTENTIATION OF CISPLATIN ANTITUMOR-ACTIVITY BY PRETREATMENT WITH SPARSOMYCIN AND ANALOGS
    HOFS, HP
    ZYLICZ, Z
    WAGENER, DJT
    DEVALKBAKKER, V
    VANDENBROEK, LAGM
    OTTENHEIJM, HCJ
    [J]. ANTICANCER RESEARCH, 1988, 8 (05) : 1094 - 1094
  • [9] POTENTIATION OF CISPLATIN ANTITUMOR-ACTIVITY ON L1210 LEUKEMIA SC BY SPARSOMYCIN AND 3 OF ITS ANALOGS
    ZYLICZ, Z
    HOFS, HP
    WAGENER, DJT
    [J]. CANCER LETTERS, 1989, 46 (02) : 153 - 157
  • [10] INVITRO MODULATION OF CISPLATIN CYTOTOXICITY BY SPARSOMYCIN INHIBITION OF PROTEIN-SYNTHESIS
    ZYLICZ, Z
    WAGENER, DJT
    VANRENNES, H
    WESSELS, JMC
    VANDERKLEIJN, E
    DEGRIP, WJ
    VANDENBROEK, LAGM
    OTTENHEIJM, HCJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1987, 78 (04) : 701 - 705
12345